Open Access Green as soon as Postprint is submitted to ZB.
MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcoma.
Cancer Genet. 205, 212-219 (2012)
Osteosarcomas are genetically complex tumors with abundant structural and numerical alterations. The molecular pathogenesis of the disease is, however, still poorly understood. Aside from various oncogenes and tumor suppressor genes, deregulated microRNAs (miRNAs) are known to influence tumor development and biology. We therefore investigated six well-established osteosarcoma cell lines (HOS58, U2-OS, Saos-2, MNNG/HOS, SJSA-1, and MG-63) for genome-wide miRNA expression (miRBase Version 15.0, http://www.mirbase.org/) and correlated our findings with gene expression. Cultured osteoblasts (hFOB 1.19) and mesenchymal stem cells (L87/4) were used as normal references. Focusing only on miRNAs that were deregulated in the majority of osteosarcoma cell lines, we identified several miRNAs with oncogenic and tumor suppressor properties, including various members of the oncogenic miR-17-92 cluster. In addition, several genes involved in differentiation (RGMB, LRRC17), cell cycle control (CCNE1), and apoptosis (LIMA1, CAMK2N1) were found to be deregulated in osteosarcoma cell lines, most likely due to altered miRNA expression patterns. Our findings indicate a crucial impact of deregulated miRNAs with consecutive changes in gene expression in osteosarcomas, which strongly suggests pathogenetic and potentially therapeutic implications.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
1.389
0.000
50
52
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Osteosarcoma; Microrna; Mirna; Mir-17-92 Cluster; Comparative Genomic Hybridization; Stromal Cell-Lines; Colon-Cancer Cells; Cycle Arrest; Apoptosis; Differentiation; P53; Chemoresistance; Identification; Suppression
Language
Publication Year
2012
HGF-reported in Year
2012
ISSN (print) / ISBN
2210-7762
Journal
Cancer Genetics
Quellenangaben
Volume: 205,
Issue: 5,
Pages: 212-219
Publisher
Elsevier
Publishing Place
New York, NY
Reviewing status
Peer reviewed
Institute(s)
Translational Metabolic Oncology (IDC-TMO)
Institute of Experimental Genetics (IEG)
Institute of Radiation Biology (ISB)
CCG Osteosarcoma (PATH-KOS)
Institute of Experimental Genetics (IEG)
Institute of Radiation Biology (ISB)
CCG Osteosarcoma (PATH-KOS)
POF-Topic(s)
30203 - Molecular Targets and Therapies
30201 - Metabolic Health
30202 - Environmental Health
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
30201 - Metabolic Health
30202 - Environmental Health
30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Research field(s)
Radiation Sciences
Genetics and Epidemiology
Enabling and Novel Technologies
Genetics and Epidemiology
Enabling and Novel Technologies
PSP Element(s)
G-501000-001
G-500600-004
G-500200-001
G-520800-001
G-500600-004
G-500200-001
G-520800-001
PubMed ID
22682620
WOS ID
WOS:000305369500003
Scopus ID
84865378998
Erfassungsdatum
2012-07-05